By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Covance Inc. 

210 Carnegie Center

Princeton  New Jersey  08540-6233  U.S.A.
Phone: 888-COVANCE Fax: 609-452-9375


Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.3 billion, global operations in more than 20 countries, and more than 8,100 employees worldwide.

Driven by a commitment to scientific, operational and service excellence, we help sponsors accomplish all of their drug development goals, including:

  • Proving early safety
  • Conducting first-in-human studies
  • Conducting proof-of-concept studies
  • Proving safety and efficacy
  • Filing for marketing approval
  • Launching and marketing a drug
  • Ensuring patient safety and access
  • Managing risk

    We focus on meeting sponsors' timelines, delivering high-quality error-free data and providing exceptional customer service to successfully advance their compounds through the drug development continuum - as safely, efficiently and cost-effectively as possible.

    Worldwide, Covance provides the following drug development services to pharmaceutical and biotechnology companies of all sizes:

  • Research Products
  • Antibody Services
  • Biomarker Services
  • Nonclinical Development Services
  • Clinical Pharmacology Services
  • Cardiac Safety Services
  • Central Laboratory Services
  • Virtual Central Laboratory Services
  • Clinical Development Services
  • Risk Management Services
  • Commercialization Services
  • Outcomes & Consulting Services

    Indianapolis – 8211 SciCor Dr / Indianapolis, IN 46214
    Greenfield - 671 South Meridian Rd/ Greenfield, IN 46140
    Madison - 3301 Kinsman Blvd./Madison, WI 53704

    Key Statistics

    Ownership: Public

    Web Site: Covance Inc.
    Employees: 8,100
    Symbol: CVD

  • Industry

    Company News
    Covance Inc. (CVD) to Hire 120 for New Space 2/25/2015 7:31:30 AM
    Laboratory Corporation of America Holdings (LabCorp) (LH) Completes Acquisition Of Covance Inc. (CVD) 2/19/2015 1:29:21 PM
    Covance Inc. (CVD) Stockholders Approve Acquisition By Laboratory Corporation of America Holdings (LabCorp) (LH) 2/18/2015 7:45:47 AM
    Covance Inc. (CVD) Reports Fourth Quarter Net Revenue Of $634 Million, Pro Forma EPS Of $0.97 And Record Adjusted Net Orders Of $823 Million 2/4/2015 8:47:18 AM
    Covance Inc. (CVD) Launches New Solution To Bridge Preclinical To Clinical Development 1/20/2015 10:27:32 AM
    Covance Inc. (CVD) Sets February 18, 2015 As Date of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Labcorp 1/12/2015 9:34:53 AM
    Covance Inc. (CVD) Investor Sues Goldman, Sachs & Co. Over Conflict-Tainted Laboratory Corporation of America Holdings (LabCorp) (LH) Advice 12/11/2014 6:13:19 AM
    Covance Inc. (CVD) Reports Third Quarter Net Revenue Growth Of 3.4% To $627 Million, Pro Forma EPS Growth Of 18.2% To $0.98 And Adjusted Net Orders Of $752 Million 11/3/2014 7:41:41 AM
    Laboratory Corporation of America Holdings (LabCorp) (LH) Snatches Up Covance Inc. (CVD) For $6.1 Billion 11/3/2014 6:02:28 AM
    Covance Inc. (CVD) Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award 10/17/2014 7:53:59 AM